Enhancement of coronary vasodilating action of adenosine by dilazep and dipyridamole in the dog.
D000241:Adenosine / Q000494:pharmacology*; D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D004176:Dipyridamole / Q000494:pharmacology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006325:Heart Atria; D007267:Injections; D007275:Injections, Intravenous; D008297:Male; D012501:Saphenous Vein; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology*
D001381:Azepines; D001565:Benzoates; D001570:Benzodiazepinones; D014665:Vasodilator Agents; D004176:Dipyridamole; D000241:Adenosine